MRNA Sep 2024 80.000 put
OPR - OPR 延遲價格。貨幣為 USD。
加入追蹤清單
市場開市。 截至 03:58PM EDT。
| 前收市價 | 0.6000 |
| 開市 | 0.4600 |
| 買盤 | 0.3900 |
| 賣出價 | 0.5600 |
| 拍板 | 80.00 |
| 到期日 | 2024-09-20 |
| 今日波幅 | 0.4600 - 0.5500 |
| 合同範圍 | 無 |
| 成交量 | |
| 未平倉合約 | 385 |
Yahoo財經美股日誌｜道指守4萬點收市 三指數最少4周連升
美股走勢反覆，三大指數收市表現各異，道瓊斯指數再創新高40,051.05點，收市首次守穩在4萬點以上；納斯達克指數輕微下跌。總結一周，三大指數均報升，納指和標普500指數連升4周，道指連升5周。
BenzingaEuropean Patent Office Sides with Moderna In COVID-19 Vaccine Patent Dispute With Pfizer/BioNTech
Moderna Inc (NASDAQ:MRNA) has reportedly achieved a significant victory at the European Patent Office (EPO) in its ongoing legal battle with Pfizer Inc (NYSE:PFE) and BioNTech SE (NASDAQ:BNTX) over the Covid-19 vaccine. The EPO’s Opposition Division upheld the validity of one of Moderna’s crucial patents, boosting the mRNA vaccine maker’s efforts to reclaim pandemic profits from its competitors, the Financial Times reports. Although Pfizer has nine months to appeal the decision, the EPO’s writte
ZacksThe Zacks Analyst Blog Highlights Novavax, Sanofi, Fulcrum Therapeutics, Moderna and Bristol Myers
Novavax, Sanofi, Fulcrum Therapeutics, Moderna and Bristol Myers are included in this Analyst Blog.
